The CARPHA Caribbean Regulatory System (CRS) has announced that it will begin charging modest user fees to the companies that apply for medicines recommendation through the CRS, starting November 15, 2019.
A release from Caribbean Public Health Agency (CARPHA) said that the CRS became operational in early 2017 and has performed these duties free of charge for over two years.
“Companies have increasingly used the system and to date have submitted over 100 medicines applications, with the CRS recommending roughly 55 of these for accelerated registration in CARICOM Member States. All are verified to be the identical medicines approved in a reference agency like the US Food and Drug Administration. This ensures the availability of the same medicines as found in highly regulated markets in CARICOM”, the release said.